Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gladys L. Alonsozana"'
Autor:
Show-Hong Duh, Fred S. Apple, Kristin Mascotti, Robert T. McCormack, Robert H. Christenson, David L. Morgan, Gladys L. Alonsozana, Joseph H. Keffer, Frank H. Wians, Marilyn D. Olson
Publikováno v:
Clinical Chemistry. 44:52-60
We evaluated the ACCESS® cardiac troponin I (cTnI) immunoassay as a marker for myocardial infarction (MI). Total imprecision was 6.0% to 13.5%, the minimum detectable concentration was 0.007 μg/L, and the limit of quantitation was 0.046 μg/L. Comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0ad2752004d338c61ea1fb4271faf79
https://doi.org/10.1093/clinchem/44.1.52
https://doi.org/10.1093/clinchem/44.1.52
Autor:
Robert L. Fitzgerald, Ellis Jacobs, Gladys L. Alonsozana, Show-Hong Duh, Marina Rozenberg, Robert H. Christenson, Luann Ochs, Wendy L. Frankel, David A. Herold
Publikováno v:
Clinical Biochemistry. 30:27-33
A qualitative whole blood rapid assay for cardiac troponin T (cTnT) was examined. The assay uses the same antibodies as for a benchmark ELISA, but the capture and detection roles were switched to enhance specificity.The cTnT Rapid Assay and ELISA wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c5e5219b4d7059304f6d925cb0ca265
https://doi.org/10.1016/s0009-9120(96)00132-4
https://doi.org/10.1016/s0009-9120(96)00132-4
Publikováno v:
Clinical Chemistry. 42:803-808
Availability of markers such as cardiac troponin T (cTnT) has brought new insights into ischemic heart disease (IHD). cTnT is a distinct protein that differs from other markers in biological function, molecular mass, and cytosolic pool. cTnT has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5d33dd2ffb75191293dc7415e35f8cf
https://doi.org/10.1093/clinchem/42.5.803
https://doi.org/10.1093/clinchem/42.5.803
Autor:
Robert H. Christenson, Mahmoud D. Elfath, Linda C. Gregory, Benjamin F. Trump, Show-Hong Duh, Colin F. Mackenzie, Gladys L. Alonsozana
Publikováno v:
Journal of cardiothoracic and vascular anesthesia. 11(7)
Objectives: Pyridoxalated hemoglobin-polyoxyethylene (PHP) is a prototypical red cell substitute approved for phase I studies. Peripheral blood smears of human blood mixed with PHP in 1 to 4 g/dL concentrations showed dose-dependent red cell aggregat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b3da547874785203903b36303f41de5
https://pubmed.ncbi.nlm.nih.gov/9412882
https://pubmed.ncbi.nlm.nih.gov/9412882
Publikováno v:
Journal of the American College of Cardiology. 27(2):358-359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8042f0fbc59a800a975e0aadc4a0847b
Autor:
Gladys L. Alonsozana, Mitchell W. Krucoff, Robert H. Christenson, Show-Hong Duh, Mary Ann O’Hanesian, Robert M. Califf, Kristina N. Sigmon, E. Magnus Ohman, Kristin L. Newby
Publikováno v:
Journal of the American College of Cardiology. (2):148A
Myoglobin (MYO), measured using a quantitative 10 minute assay, was examined in combination with clinical variables for assessing infarct related artery (IRA) patency in 96 MI pts, all of whom received front-loaded thrombolytic therapy (TT) at a medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59be851f00fa34b62bac74f515a82ab6